CGMs Go Over-The-Counter – The Good and the Bad

Continuous glucose monitoring (CGM) is now available without a prescription in the United States. Our founder Jennifer Okemah and Diana Isaacs, an Endocrinology Clinical Pharmacy Specialist, were invited by Justin Eastzer, Founder & Host of Diabetech, to discuss these new technologies. This episode explores the mechanism of these biosensors, as well as the benefits and drawbacks of the data and feedback they provide. It also takes a broader look at issues like health insurance’s role, the implications for those without access to CGMs, and the potential risk faced by those who misinterpret glucose readings.